(Q40518870)

English

Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer

scientific article published on September 2004

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1 reference

based on heuristic

inferred from title

ovarian carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Kimberly R Kalli

1

object named as

Kimberly R Kalli

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

author name string

Sarah V Bradley

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Susanne Fuchshuber

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Cheryl A Conover

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

language of work or name

0 references

publication date

1 September 2004

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

94

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

705-712

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.059

7 January 2021

Cancer of the ovary

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.059

7 January 2021

Recent cancer trends in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.059

7 January 2021

Biological characterization of human epithelial ovarian carcinoma cells in primary culture: the insulin-like growth factor system

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.059

7 January 2021

Clinical significance of expression of estrogen receptor alpha and beta mRNAs in ovarian cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.059

7 January 2021

Responsiveness of patients with advanced ovarian carcinoma to tamoxifen. A Gynecologic Oncology Group study of second-line therapy in 105 patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.059

7 January 2021

Growth inhibition of oestrogen receptor-positive human ovarian carcinoma by anti-oestrogens in vitro and in a xenograft model

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.059

7 January 2021

The regulation of growth and protein expression by estrogen in vitro: a study of 8 human ovarian carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.059

7 January 2021

BG-1 ovarian cell line: an alternative model for examining estrogen-dependent growth in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.059

7 January 2021

SKOV3 ovarian carcinoma cells have functional estrogen receptor but are growth-resistant to estrogen and antiestrogens

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.059

7 January 2021

Epidermal growth factor receptor signaling and the invasive phenotype of ovarian carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.059

7 January 2021

Epidermal growth factor-related peptides and their receptors in human malignancies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.059

7 January 2021

Epidermal growth factor, oestrogen and progesterone receptor expression in primary ovarian cancer: correlation with clinical outcome and response to chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.059

7 January 2021

The growth factor receptors HER-2/neu and EGFR, their relationship, and their effects on the prognosis in early stage (FIGO I-II) epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.059

7 January 2021

Crosstalk between the insulin-like growth factors and estrogens in breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.059

7 January 2021

Bidirectional signaling between the estrogen receptor and the epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.059

7 January 2021

Insulin and interleukin-4 induce desensitization to the mitogenic effects of insulin-like growth factor-I. Pivotal role for insulin receptor substrate-2

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.059

7 January 2021

Phase I and clinical evaluation of a pharmacologically guided regimen of suramin in patients with hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.059

7 January 2021

Phase I study of suramin given by intermittent infusion without adaptive control in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.059

7 January 2021

Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.059

7 January 2021

Inhibition of insulin like growth factor II autocrine growth of Wilms' tumor by suramin in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.059

7 January 2021

Suramin blockade of insulinlike growth factor I-stimulated proliferation of human osteosarcoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.059

7 January 2021

Suramin-induced growth inhibition and insulin-like growth factor-I binding blockade in human breast carcinoma cell lines: potentially related events

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.059

7 January 2021

A phase I study of suramin with once- or twice-monthly dosing in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.059

7 January 2021

Endocrine Factors in Common Epithelial Ovarian Cancer*

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.059

7 January 2021

Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.059

7 January 2021

Epidermal growth factor receptor: a promising target in solid tumours

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.059

7 January 2021

Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.059

7 January 2021

Suramin, an experimental chemotherapeutic drug, activates the receptor for epidermal growth factor and promotes growth of certain malignant cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.059

7 January 2021

Suramin rapidly alters cellular tyrosine phosphorylation in prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.059

7 January 2021

Pleiotropic actions of suramin on the proliferation of human breast-cancer cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.059

7 January 2021

Mechanisms of growth stimulation by suramin in non-small-cell lung cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.059

7 January 2021

Epidermal growth factor receptor and tyrosine phosphorylation of estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.059

7 January 2021

The multifaceted mechanisms of estradiol and estrogen receptor signaling.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.05.059

7 January 2021

Identifiers

10.1016/J.YGYNO.2004.05.059

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40518870&oldid=1899835571"